X0202 SCHEDULE 13G 0001390202 XXXXXXXX LIVE Common Stock, $0.0001 par value 06/30/2026 0001280776 IMMUNIC, INC. 4525EP200 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 Rule 13d-1(b) Laurion Capital Management LP DE 0 839526 0 839526 839526 N 6.06 IA PN Benjamin Alexander Smith X1 0 839526 0 839526 839526 N 6.06 HC IN Janaka Sheehan Maduraperuma X0 0 839526 0 839526 839526 N 6.06 HC IN IMMUNIC, INC. 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, UNITED STATES 10036 This statement is filed by: (i) Laurion Capital Management LP ("Laurion Capital"), a Delaware limited partnership, and the investment adviser to certain funds and accounts (the "Laurion Funds"), with respect to the shares of Common Stock (as defined in Item 2(d) below) directly held by the Laurion Funds; (ii) Mr. Benjamin Alexander Smith ("Mr. Smith"), the co-managing member of Laurion Capital GP LLC, the general partner of Laurion Capital, with respect to the shares of Common Stock directly held by the Laurion Funds. (iii) Mr. Janaka Sheehan Maduraperuma ("Mr. Maduraperuma"), the co-managing member of Laurion Capital GP LLC, the general partner of Laurion Capital, with respect to the shares of Common Stock directly held by the Laurion Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein. The address of the business office of each of the Reporting Persons is 360 Madison Avenue, Suite 1900, New York, NY 10017. Laurion Capital is a Delaware limited partnership. Mr. Smith is a citizen of the United States. Mr. Maduraperuma is a citizen of the United Kingdom. N IA HC As of June 30, 2026, the Reporting Persons may be deemed to beneficially own an aggregate of 839,526 shares of common stock, par value $0.0001 per share (the "Common Stock") of Immunic, Inc. (the "Issuer"), consisting of (i) 610,326 shares of Common Stock; and (ii) 229,200 shares of Common Stock issuable upon the exercise of warrants issued by the Issuer. The ownership percentages reported herein are based on 13,621,526 shares of Common Stock reported as issued and outstanding as of March 31, 2026 in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026, plus 229,200 shares of Common Stock which the Laurion Funds may acquire upon the exercise of the warrants. 6.06 Laurion Capital Management LP - 0 Benjamin Alexander Smith - 0 Janaka Sheehan Maduraperuma - 0 Laurion Capital Management LP - 839,526 Benjamin Alexander Smith - 839,526 Janaka Sheehan Maduraperuma - 839,526 Laurion Capital Management LP - 0 Benjamin Alexander Smith - 0 Janaka Sheehan Maduraperuma - 0 Laurion Capital Management LP - 839,526 Benjamin Alexander Smith - 839,526 Janaka Sheehan Maduraperuma - 839,526 Y N See Item 2. The Laurion Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock reported herein. Laurion Capital Master Fund Ltd., a Laurion Fund, has the right to receive or the power to direct the receipt of dividends or the proceeds from the sale of more than 5% of the shares of Common Stock. N See Item 2(a) and Item 3 Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Laurion Capital Management LP Jason Riesel 08/04/2026 Benjamin Alexander Smith Benjamin Alexander Smith 08/04/2026 Janaka Sheehan Maduraperuma Janaka Sheehan Maduraperuma 08/04/2026